Bruker Q1 revenue rises 11% to $801.4 million, but company lowers 2025 EPS and organic growth outlook
Bruker reported first quarter 2025 revenue of $801.4 million, up 11.0% year over year, but non-GAAP diluted EPS fell 11.3% to $0.47 and GAAP diluted EPS was $0.11, down from $0.35. The company lowered its full-year 2025 organic revenue growth and non-GAAP EPS guidance, citing academic market and tariff dynamics, which points to a weaker profit outlook for shareholders.
Key points
- Q1 2025 revenue $801.4 million, up 11.0%; organic revenue growth 2.9%
- Q1 non-GAAP diluted EPS $0.47, down 11.3% from $0.53; GAAP diluted EPS $0.11 vs. $0.35
- FY 2025 non-GAAP EPS guidance $2.40 to $2.48, implying 0% to 3% growth; organic revenue growth 0% to 2%
- Q1 non-GAAP operating margin 12.7% vs. 14.0% a year earlier
The filing
Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.